BridgeMD
New treatment option for Radiation-Induced Oral Mucositis
Official title Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer
ClinicalTrials.gov ID: NCT07242859
What this study is testing
- What it's testing
- This study aims to find out if taking rice bran supplements can help reduce the painful mouth sores (oral mucositis) that often occur in patients with head and neck cancer who receive radiation therapy. The trial will include adult patients undergoing radiation treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female patients of age 18 years old tor more
- Patients with squamous cell carcinomas without metastases of other non-head and non-neck tumors.
- Patients undergoing radiotherapy with an ECOG performance status of 0, 1, or 2
- Patients who will receive IMRT delivered as radical or adjuvant therapy with or without concurrent chemotherapy
- Ready to provide written informed consent
You likely can't join if
- Receiving any other approved or investigational anti-cancer agent than those specified in this study.
- Pregnant or breastfeeding female patients
- Patients who have oral lesions unrelated to treatment or cancer,
- Patients who are on drugs that could cause oral lesions or are using anticoagulants.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.